Citation Impact
Citing Papers
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol
1996
ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome
2006
The LDL modification hypothesis of atherogenesis: an update
2008
Plasma lipoproteins: apolipoprotein structure and function.
1984
Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein.
1989
The DNA-damage response in human biology and disease
2009 StandoutNature
Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions
2000
Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
1992
Role of macrophage scavenger receptors in atherosclerosis
2012
Inflammation and Alzheimer's disease
2000 Standout
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
2006
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages
2006
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Mechanisms for the Formation of Isoprostane Endoperoxides from Arachidonic Acid
2003
Modified plasma-derived lipoproteins in human atherosclerotic plaques
1988
Inflammation and metabolic disorders
2006 StandoutNature
Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis
2001
Role of oxidatively modified LDL in atherosclerosis
1990
Oscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII*1
2004
Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration
2001
Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
2010
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
2006
The role of vitamin E in atherosclerosis
2003
Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pH
1998
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Cell signaling by reactive nitrogen and oxygen species in atherosclerosis
2000
Autophagy Links Inflammasomes to Atherosclerotic Progression
2012
Myeloperoxidase produces nitrating oxidants in vivo
2002
Interactions of Nitric Oxide and Peroxynitrite with Low-Density Lipoprotein
2002
Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary Syndromes
2001
Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low‐density lipoproteins
2007
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
1989 Standout
Myeloperoxidase-derived Reactive Chlorinating Species from Human Monocytes Target Plasmalogens in Low Density Lipoprotein
2003
Class B Scavenger Receptors CD36 and SR-BI Are Receptors for Hypochlorite-modified Low Density Lipoprotein
2003
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction
2001
Continuous Monitoring ofin VztroOxidation of Human Low Density Lipoprotein
1989 Standout
Prelesional events in atherogenesis
1987
Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.
1991
The role of oxidized phospholipids in atherosclerosis
2008
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
2006
Unraveling peroxynitrite formation in biological systems
2001
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
1990
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid–protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins
1999
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.
1998
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors
2004
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
A Tale of Two Controversies
2002
Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system
1998
Eater, a Transmembrane Protein Mediating Phagocytosis of Bacterial Pathogens in Drosophila
2005 StandoutNobel
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice
2000
Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights
2004
Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species
2004
Eosinophil Peroxidase Nitrates Protein Tyrosyl Residues
1999
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Phosphocholine as a pattern recognition ligand for CD36
2005
Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages
1995
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits
1990
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
2001
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
CD36 and atherosclerosis
2000
Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II
2007
Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix
1999
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Regulation of protein function by S‐glutathiolation in response to oxidative and nitrosative stress
2000
Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
2005
Contribution of Myeloperoxidase to Smoking-dependent Vascular Inflammation
2008
Mechanism of Reaction of Myeloperoxidase with Nitrite
2000
Myeloperoxidase binds to low‐density lipoprotein: potential implications for atherosclerosis
2000
Role of superoxide in endothelial-cell modification of low-density lipoproteins
1988
Exosome poly‐ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro‐atherothombotic cellular functions
2014
Hypochlorite-Modified (Lipo)Proteins Are Present in Rabbit Lesions in Response to Dietary Cholesterol
2001
Myeloperoxidase-generated oxidants and atherosclerosis
2000
Increased atherosclerosis in myeloperoxidase-deficient mice
2001
Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C
1990
Resistance in the anti-angiogenic era: nay-saying or a word of caution?
2003
Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases
2000
Biochemistry of the Arterial Wall in Developing Atherosclerosisa
1991
Atherosclerosis — An Inflammatory Disease
1999 Standout
Inflammation in atherosclerosis
2002 StandoutNature
Origin and physiological roles of inflammation
2008 StandoutNature
Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
1990 Nature
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
1991
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
The Oxidation of Lipoproteins by Monocytes-Macrophages
1999
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
2001
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
2003
CD36 and macrophages in atherosclerosis
2007
Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?
2005
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
2009
Atherosclerosis
2000 StandoutNature
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
2013
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
2004
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
2006
Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions
2000
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Atherosclerosis
2001 Standout
Group V Secretory Phospholipase A2-modified Low Density Lipoprotein Promotes Foam Cell Formation by a SR-A- and CD36-independent Process That Involves Cellular Proteoglycans
2005
Role of oxidized low density lipoprotein in atherogenesis.
1991 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development
2005
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Angiogenesis as a therapeutic target
2005 StandoutNature
Monocytes in atherosclerosis: subsets and functions
2010
Autophagy in immunity and inflammation
2011 StandoutNature
Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosis
2002
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
2003
Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2
2009 StandoutNobel
CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
2001
Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy
2003
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques
2012
Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic
1985
Atherosclerosis: Scavenger cell receptor shared
1985 StandoutNatureNobel
Inhibition of Ca2+ accumulation in mitogen-activated lymphocytes: role of membrane-bound plasma lipoproteins.
1980
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
1992 StandoutNobel
Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima.
1992
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
1994
Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity
2011
Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors.
1993
A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation
2003
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.
2001
The Problem of Passenger Genes in Transgenic Mice
2007
Endothelial Responses to Oxidized Lipoproteins Determine Genetic Susceptibility to Atherosclerosis in Mice
2000
Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.
1991
7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein.
1994
Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions.
1989
INFLAMMATION AND ALZHEIMERS DISEASE
2000
Lipoproteins and atherosclerosis. A look back and a look ahead.
1983
Atherogenesis: a postprandial phenomenon.
1979 Standout
Oxidized Low-Density Lipoprotein and Atherosclerosis
2010
[1] Role of free radicals and catalytic metal ions in human disease: An overview
1990 Standout
Lipoprotein and albumin accumulation in reendothelialized and deendothelialized aorta.
1984
Tocopherol‐mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement
1999
Scavenger Receptors in Atherosclerosis
2006
The action of defined oxygen-centred free radicals on human low-density lipoprotein
1989
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.
1990
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation.
1987
Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in Plasma
2006
Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells.
1985
A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.
2003
Mechanisms of Plaque Formation and Rupture
2014 Standout
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima.
1988
Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle.
1990
Oxidative Stress, Caloric Restriction, and Aging
1996 StandoutScience
Copper-Catalyzed Synthesis of Mixed Alkyl Aryl Phosphonates
2014 StandoutNobel
Vitamin E Oxidation in Human Atherosclerotic Lesions
2002
Measurement in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta. Predominance of intimal degradation.
1984
A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
1992
Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species
2000
Hypercholesterolemia and atherosclerosis change vascular reactivity in rabbits by different mechanisms.
1991
Neuroimmune Guidance Cue Semaphorin 3E Is Expressed in Atherosclerotic Plaques and Regulates Macrophage Retention
2013
Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein.
1993
Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration
2001
Glycosaminoglycans and apolipoproteins B and A-I in human aortas. Chemical and immunological analysis of lesion-free aortas from children and adults.
1987
Interleukin‐10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice
2010
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
1987
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Myeloid Krüppel-Like Factor 4 Deficiency Augments Atherogenesis in ApoE −/− Mice—Brief Report
2012
Nitric oxide, oxidants, and protein tyrosine nitration
2004
Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis
2004 Science
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
2004 StandoutScience
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation.
1984
Regulation of innate immune responses by autophagy-related proteins
2010
A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism.
1990
The Response-to-Retention Hypothesis of Early Atherogenesis
1995
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
1994
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Hypoxia Induces Netrin-1 and Unc5b in Atherosclerotic Plaques
2013
Myeloperoxidase produces nitrating oxidants in vivo
2002
Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits.
1988
Lipoproteins in human atherosclerotic vessels
1979
Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor.
1991
Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit.
1986
Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic Rabbits
1988 Science
Coexistence of Oxidized Lipids and α-Tocopherol in All Lipoprotein Density Fractions Isolated From Advanced Human Atherosclerotic Plaques
1999
Role of endothelial cells and their products in the modification of low-density lipoproteins
1986
LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.
1994
Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages.
1992
Role of Monocytes in Atherogenesis
2003
CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the Heart
2002
Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice
2008
Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
1987
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
When Translation Meets Metabolism: Multiple Links to Diabetes
2003
Insulin Resistance and Atherosclerosis
2006
Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
2008
Stimulation of cholesteryl ester synthesis in macrophages by extracts of atherosclerotic human aortas and complexes of albumin/cholesteryl esters.
1981 StandoutNobel
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
2004
Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages.
1991
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Deficiency of Myeloperoxidase Increases Infarct Volume and Nitrotyrosine Formation in Mouse Brain
2002
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.
1992
Works of Henry F. Hoff being referenced
Non-conventional modification of low density lipoproteins: chemical models for macrophage recognition of oxidized LDL
1997
Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages
1988
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
1999
Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36
2002
Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues
2002
LDL accumulation in the grossly normal human iliac bifurcation and common iliac arteries
1989
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
2000
Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages
2002
Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation
1995
Modification of human serum low density lipoprotein by oxidation — Characterization and pathophysiological implications
1987
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
2000
Macrophage degradation of LDL extracted from human aortic plaques: Effect of isolation conditions
1991
A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions
2002
The Interaction of Apolipoprotein-Serine with Phosphatidylcholine
1974
Quantitation of apo b in human aortic fatty streaks A comparison with grossly normal intima and fibrous plaques
1978
Localization of Apo-Lipoproteins in Human Carotid Artery Plaques
1975
Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions
1979
Lipoproteins Containing Apo B Extracted from Human Aortas Structure and Functiona
1985
Uptake by mouse peritoneal macrophages of large cholesteryl ester-rich particles isolated from human atherosclerotic lesions
1987
Localization of LDL in Arteries: Improvements in Immunofluorescence Procedures a
1983
HNE-Derived 2-Pentylpyrroles Are Generated during Oxidation of LDL, Are More Prevalent in Blood Plasma from Patients with Renal Disease or Atherosclerosis, and Are Present in Atherosclerotic Plaques
2000
Accumulation of lipoproteins containing apo B in the aorta of cholesterol-fed cynomolgus monkeys
1982
Plasma low density lipoprotein accumulation in aortas of hypercholesterolemic swine correlates with modifications in aortic glycosaminoglycan composition
1986
Lipoproteins containing apolipoprotein A-I extracted from human aortas
1982
(Carboxyalkyl)pyrroles in Human Plasma and Oxidized Low-Density Lipoproteins
1997
Ultrastructural localization of apolipoprotein B in human aortic and coronary atherosclerotic plaques
1977
Localization of low-density lipoproteins in atherosclerotic lesions from human normolipemics employing a purified fluorescent-labeled antibody
1974
Ultrastructural localization of plasma lipoproteins in human intracranial arteries
1975
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
2000
Isolation, purification, and characterization of a lipoprotein containing apo B from the human aorta
1982
Formation of Nitric Oxide–Derived Oxidants by Myeloperoxidase in Monocytes
1999
Detergent extraction of tightly-bound apoB from extracts of normal aortic intima and plaques
1978